Researcher profile · Semantic Scholar

Marie-Bernadette Aretin

h-index: 9
Works: 23
Citations: 732

Most-cited papers

A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection.
F. Eskandary, H. Regele, L. Baumann, G. Bond +13 more
2017Journal of the American Society of Nephrology259 citations Open access
Semantic Scholar
Incidence, risk factors and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.
F. Moik, W-S.e Chan, Sarah Wiedemann, C. Hoeller +7 more
2020Blood206 citations Open access
Semantic Scholar
First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia.
B. Boidol, C. Kornauth, E. van der Kouwe, N. Prutsch +18 more
2017Blood64 citations Open access
Semantic Scholar
Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases
R. Bartsch, A. Berghoff, J. Furtner, M. Marhold +22 more
2024Neuro-Oncology62 citations
Semantic Scholar
Safety and tolerability of topically administered autologous, apoptotic PBMC secretome (APOSEC) in dermal wounds: a randomized Phase 1 trial (MARSYAS I )
E. Simader, Denise Traxler, M. Kasiri, Helmut Hofbauer +17 more
2017Scientific Reports29 citations Open access
Semantic Scholar
Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy
C. Minichsdorfer, A. Gleiss, Marie-Bernadette Aretin, M. Schmidinger +1 more
2022Annals medicus23 citations Open access
Semantic Scholar
Docetaxel plus cetuximab biweekly is an active regimen for the first-line treatment of patients with recurrent/metastatic head and neck cancer
Doris Posch, H. Fuchs, G. Kornek, A. Grah +3 more
2016Scientific Reports23 citations Open access
Semantic Scholar
Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II study.
T. Fuereder, C. Minichsdorfer, M. Mittlboeck, C. Wagner +7 more
2021Oral Oncology18 citations Open access
Semantic Scholar
Modified biweekly cisplatin, docetaxel plus cetuximab (TPEx) as first-line treatment for patients with recurrent/metastatic head and neck cancer
H. Fuchs, J. Pammer, C. Minichsdorfer, Doris Posch +3 more
2018Medical Oncology11 citations Open access
Semantic Scholar
Denosumab for Prevention of Acute Onset Immobilization‐Induced Alterations of Bone Turnover: A Randomized Controlled Trial
L. Wadiura, Maria Butylina, A. Reinprecht, Marie-Bernadette Aretin +4 more
2022Journal of Bone and Mineral Research9 citations Open access
Semantic Scholar
Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer
S. Wagner, T. Magnes, T. Melchardt, Dominik Kiem +9 more
2023Anticancer Research8 citations Open access
Semantic Scholar
Corticosteroid therapy in older adults with cancer: Expert recommendations from a task force of the International Society of Geriatric Oncology.
R. Bartsch, D. Aletaha, T. Fuereder, Matti Aapro +6 more
2024Journal of Geriatric Oncology6 citations Open access
Semantic Scholar
Antibody–drug conjugates—the magic bullet?
Marie-Bernadette Aretin
2022memo - Magazine of European Medical Oncology6 citations Open access
Semantic Scholar
Determination of Extravasation Effects of Nal-Iri and Trabectedin and Evaluation of Treatment Options for Trabectedin Extravasation in a Preclinical Animal Model
O. Keritam, V. Juhász, C. Schöfer, C. Thallinger +5 more
2022Frontiers in Pharmacology4 citations Open access
Semantic Scholar
Obstipation and diarrhoea in palliative care—a pharmacist’s view
Marie-Bernadette Aretin
2020memo - Magazine of European Medical Oncology2 citations Open access
Semantic Scholar
921P Pembrolizumab plus docetaxel for the treatment of recurrent metastatic head and neck cancer: A prospective phase I/II study
T. Fuereder, C. Minichsdorfer, M. Mittlboeck, C. Wagner +5 more
20202 citations Open access
Semantic Scholar
124P Serum parameters as prognostic biomarkers for anti PD-1/PD-L1 therapy in patients with solid tumours: A retrospective data analysis
C. Minichsdorfer, A. Gleiss, Marie-Bernadette Aretin, M. Schmidinger +1 more
20201 citations Open access
Semantic Scholar
Severe Immune‐Related Neurological Adverse Events Associated With Immune Checkpoint Inhibitor Treatment: A Retrospective Single‐Center Study
A. Grisold, A. Starzer, S. Silvaieh, M. Krenn +7 more
2026European Journal of Neurology0 citations Open access
Semantic Scholar
Abstract PO2-04-05: FINAL OUTCOME ANALYSIS FROM THE PHASE II TUXEDO-1 TRIAL OF TRASTUZUMAB-DERUXTECAN IN HER2-POSITIVE BREAST CANCER PATIENTS WITH ACTIVE BRAIN METASTASES
R. Bartsch, A. Berghoff, J. Furtner, M. Marhold +22 more
2024Cancer Research0 citations
Semantic Scholar
Denosumab for prevention of immobilization-induced alterations of bone turnover in patients admitted to a neurosurgical intensive care unit: a randomized controlled trial
L. Wadiura, Maria Butylina, A. Reinprecht, Marie-Bernadette Aretin +5 more
20220 citations
Semantic Scholar
1824P Incidence, risk factors and clinical outcome of venous and arterial thromboembolism in patients treated with immune-checkpoint inhibitors
F. Moik, W-S.e Chan, Sarah Wiedemann, C. Höller +7 more
2020Annals of Oncology0 citations Open access
Semantic Scholar
Retrospective single-center outcome analysis of neoadjuvant and palliative treatment with dual trastuzumab and pertuzumab in HER2-positive breast cancer.
M. Marhold, L. Ionce, A. Christ, Marie-Bernadette Aretin +6 more
2019Journal of Clinical Oncology0 citations
Semantic Scholar
Safety and tolerability of topically administered autologous, apoptotic PBMC secretome (APOSEC) in dermal wounds: a randomized Phase 1 trial (MARSYAS I )
E. Simader, Denise Traxler, M. Kasiri, Helmut Hofbauer +17 more
2017Scientific Reports0 citations Open access
Semantic Scholar

A. Berghoff

×3

M. Marhold×3

M. Preusser×3

A. Gleiss×3

C. Wagner×3

F. Moik×2

W-S.e Chan×2

Sarah Wiedemann×2